Neutra Arm Readies for Release of Sports Cream

Sponsored:

By:
Dylan Sikes – AllPennyStocks.com News

Monday, October 7, 2019

Neutra Corp. (OTC:NTRR) flourished Monday, on news generated by one of its subsidiaries.

Sugarland, Texas-based VIVIS Corp. is reportedly gearing up for the market release of a new transdermal, hemp-based sports cream it says will prove popular with amateur athletes and others seeking relief after tough workouts and performances.

“The announcement,” said Monday’s news release, “is the latest in a series of bold initiatives Neutra undertook earlier this year to grab a share of a market analysts predict will hit $11 billion by 2026.”

Said Neutra CEO Sydney Jim, “We’re now seeing the positive payoff of hiring a dedicated sports medicine advisor earlier this year. Our goal with that hire was to develop hemp-based CBD (cannabidiol) products geared to the expanding sports market.

As more people participate in sports or exercise, many experience some type of discomfort. While some types of pain may require professional help, says the release, most discomfort can be treated in other ways, such as through creams and topical. This represents a sizable potential market for VIVIS’s upcoming hemp-based sports cream.

Shares galloped 50% early Monday afternoon to nine-100ths of a cent, on volume topping 11.1 million shares.

Disclaimer

By clicking on the "Start Viewing AllPennyStocks.com Pro Articles" button below, you are confirming that you
understand and accept that the content we are showing you is not meant to be used as financial advice. This
content is merely for educational purposes and shows our readers real-time examples of trading strategies
based on technical and fundamental analysis principles, along with stock market commentary.

Investing in stocks is risky stuff, trust us on that one, and past performance may not be indicative of future
performance.

We want everyone to enjoy this information for its educational value, and we remind
everyone that we are not liable for losses or damages of any kind from trading based on our information. The
only thing we will recommend is to consult with a financial advisor prior to making any trades.

With that said, if we're on the same page here and you agree to our disclaimer, click the button below and
enjoy all of our AllPennyStocks.com Pro content.